258 13F filers hold it · +14 against the quarter before · shares held +33.3%
Holdings of 06/30StocksIs Wall Street adding or cutting?+14 Who bought more than 5%?5.5%
All tracked funds
All 5% stake reports on Relay Therapeutics
Relay Therapeutics RLAY
Health care sectorNasdaq
What to see in Relay Therapeutics now
Commodore Capital holds 5.5% · −4.4pp on the report before
Filed 08/14Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, Massachusetts
- Fiscal year end
- 12/31
- Next earnings
- 11/07, estimated
- 258 13F filers hold it · +14 against the quarter before · shares held +33.3%Holdings of 06/30
- Commodore Capital holds 5.5% · −4.4pp on the report beforeFiled 08/14
Funds
13F filers: 258 · +14 since the quarter before · 06/30 holdings
Famous funds that held Relay Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsRelay Therapeutics RLAY · 06/30 holdings | $1.8M | No quarter before |
| Mirae Asset Global InvestmentsRelay Therapeutics RLAY · 06/30 holdings | $179.5K | Added +2.9% |
| Duquesne Family OfficeRelay Therapeutics RLAY · 06/30 holdings | $6,530 | New position |
5% stakes
| Holder | ||
|---|---|---|
| Commodore Capital08/14 | 5.5%12,000,000 sh | −4.4pp |
| Perceptive Advisors08/10 | 6.4%14,106,187 sh | −3.6pp |
| FMR08/06 | 9.4%20,015,113.24 sh | First report |
| Point72 Asset Management05/15 | 0%0 sh | −7.8pp |
| Perceptive Advisors04/13 | 9.99%438,471 sh | +4.7pp |
| Vanguard Group03/27 | 0%0 sh | −5.5pp |
| Perceptive Advisors03/19 | 5.3%9,404,725 sh | First report |
| Commodore Capital25/11/14 | 9.9%17,000,000 sh | +2.1pp |
| Commodore Capital25/08/14 | 7.8%13,350,000 sh | +2.0pp |
| Point72 Asset Management25/08/14 | 7.8%13,445,704 sh | +2.1pp |
| Vanguard Group25/07/29 | 5.47%9,379,851 sh | −1.7pp |
| Commodore Capital25/05/15 | 5.8%10,000,000 sh | First report |
| BlackRock25/04/17 | 6.1%10,308,012 sh | −2.7pp |
| Point72 Asset Management25/03/20 | 5.7%9,694,217 sh | First report |
